For Stage 4 Non-Hodgkin Lymphoma (NHL), the five-year relative survival rate is approximately 55.2%. However, it's important to understand that these statistics are based on data from people diagnosed between 2011-2017, and survival rates have been steadily improving with advances in treatment options.
Being in remission Show Full Answer
For Stage 4 Non-Hodgkin Lymphoma (NHL), the five-year relative survival rate is approximately 55.2%. However, it's important to understand that these statistics are based on data from people diagnosed between 2011-2017, and survival rates have been steadily improving with advances in treatment options.
Being in remission is a positive indicator for long-term survival. The overall five-year survival rate for all NHL cases is 74%, but individual outcomes can vary significantly based on:
• The specific type of NHL
• Your individual response to treatment
• Your overall health
• Your age Current survival rates may actually be better than these statistics suggest, as new targeted therapies and treatment advances continue to improve outcomes. Many people with NHL can live long, fulfilling lives after achieving remission, particularly with proper follow-up care and monitoring.
September 13, 2025
Join
Your Privacy Choices
